ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Budapest, Budapest, HUN:

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer (DUO-E)

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 202 other locations

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...

Enrolling
Endometrial Cancer
Drug: Navtemadlin
Drug: Navtemadlin Placebo

Phase 2, Phase 3

Kartos Therapeutics
Kartos Therapeutics

Budapest, Hungary and 82 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

Budapest, Hungary and 162 other locations

study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer...

Enrolling
Endometrial Cancer
Breast Cancer
Drug: AZD8205 and AZD2936 (Rilvegostomig)
Drug: AZD8205

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Budapest, Hungary and 61 other locations

cell, pancreatic and biliary duct, endometrial, melanoma and urothelial tumors. This study contains two parts, single agent dose e...

Active, not recruiting
Endometrial Cancer
Bile Duct Cancer
Drug: PF-06940434
Drug: PF-06801591

Phase 1

Pfizer
Pfizer

Komárno, Slovakia and 40 other locations

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....

Enrolling
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Budapest, Hungary and 76 other locations

is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients with malignant solid tumors...

Active, not recruiting
Endometrial Carcinoma
Non-small Cell Lung Cancer
Biological: Acasunlimab in combination with pembrolizumab (in a separate expansion cohort)
Biological: Acasunlimab in combination with docetaxel (in a single expansion cohort)

Phase 1, Phase 2

Genmab
Genmab

Törökbálint, Hungary and 56 other locations

in women with mismatch repair deficient (dMMR) advanced or recurrent endometrial carcinoma who have not previously been treated with prior s...

Active, not recruiting
Endometrial Neoplasms
Biological: pembrolizumab
Drug: docetaxel

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Budapest, Hungary and 194 other locations

The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.

Enrolling
Solid Tumors
Drug: Bemarituzumab

Phase 1, Phase 2

Amgen
Amgen

Budapest, Hungary and 113 other locations

for an analysis called cervical cytology (if applicable)* take an endometrial biopsy, a small piece of tissue from the lining of the womb (c...

Active, not recruiting
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
Hot Flashes
Drug: Placebo
Drug: Elinzanetant (BAY3427080)

Phase 3

Bayer
Bayer

Szekesfehervar, Hungary and 103 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems